William R. DeFoor Jr., MD, MPH
Director, Clinical Research
is a pediatric urologist conducting a multi-institutional clinical trial to assess outcomes in vesico-ureteral reflux. Other studies include outcomes in neurogenic bladder (NGB), urinary biomarkers in ureteropelvic junction obstruction, complications of clean intermittent catheterization, urinary metabolic evaluations in bariatric patients, and UTI prevention with gentamicin bladder irrigations.
Elizabeth C. Jackson, MD
Director, Healthy Bladder Clinic
has clinical research in types of bedwetting alarms that are useful for nocturnal enuresis, in outcomes of neurogenic bladder, and in the relationship of obesity and kidney stones as well as industry sponsored research in anticholinergics for neurogenic bladder.
Brian A. Vanderbrink, MD
Urologist, Division of Urology
is an attending urologist who has strong interest in conducting clinical outcomes research, specifically in the area of lower urinary tract dysfunction. He works closely in collaboration with urology colleagues and the Colorectal Center to report and improve the urologic outcomes of patients with anorectal malformations. Reducing the incidence of urinary tract infection is another area of interest that includes examining the role innovative methods such as probiotics and hydrophilic catheters in small clinical trials.